135 related articles for article (PubMed ID: 10215484)
1. Effects of hepatic impairment on the metabolism of fructose and 5-fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS.
Otsuka H; Harada M; Koga K; Nishitani H
Magn Reson Imaging; 1999 Feb; 17(2):283-90. PubMed ID: 10215484
[TBL] [Abstract][Full Text] [Related]
2. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
Harada M; Nishitani H; Shirahama T; Koga K; Miura I
Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
4. Effect of ethanol and fructose on liver metabolism: a dynamic 31Phosphorus magnetic resonance spectroscopy study in normal volunteers.
Boesch C; Elsing C; Wegmüller H; Felblinger J; Vock P; Reichen J
Magn Reson Imaging; 1997; 15(9):1067-77. PubMed ID: 9364953
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro 31P magnetic resonance spectroscopic studies of the hepatic response of healthy rats and rats with acute hepatic damage to fructose loading.
Lu W; Locke SJ; Brauer M
Magn Reson Med; 1994 May; 31(5):469-81. PubMed ID: 8015399
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of tegafur in rat liver observed by in vivo 19F magnetic resonance spectroscopy and chromatography.
Harada M; Nishitani H; Koga K; Miura I; Umeno Y
Jpn J Cancer Res; 1992 Apr; 83(4):387-91. PubMed ID: 1506273
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
Brix G; Bellemann ME; Haberkorn U; Gerlach L; Lorenz WJ
Nucl Med Biol; 1996 Oct; 23(7):897-906. PubMed ID: 8971857
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
[TBL] [Abstract][Full Text] [Related]
9. Early detection of cancer cachexia in the rat using 31P magnetic resonance spectroscopy of the liver and a fructose stress test.
Gehman KE; Inculet RI; Brauer M; Marsh GD; Driedger AA; Thompson RT
NMR Biomed; 1996 Sep; 9(6):271-5. PubMed ID: 9073305
[TBL] [Abstract][Full Text] [Related]
10. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
[TBL] [Abstract][Full Text] [Related]
11. A new method for the evaluation of the liver injury by 19F MRS of 5-fluorouracil.
Harada M; Koga K; Miura I; Nishitani H
Magn Reson Med; 1991 Dec; 22(2):499-504. PubMed ID: 1812383
[TBL] [Abstract][Full Text] [Related]
12. High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
Jeon MJ; Lee Y; Ahn S; Lee C; Kim OH; Oh BC; Yu U; Kim H
Acta Radiol; 2015 Sep; 56(9):1051-60. PubMed ID: 25270373
[TBL] [Abstract][Full Text] [Related]
13. Assessment of energy status and fructose metabolism of liver in obstructive jaundice by 31P magnetic resonance spectroscopy.
Kainuma O; Asano T; Ikehira H; Ogawa E; Isono K
J Gastroenterol Hepatol; 1997 Nov; 12(11):740-4. PubMed ID: 9430039
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
Gonen O; Murphy-Boesch J; Li CW; Padavic-Shaller K; Negendank WG; Brown TR
Magn Reson Med; 1997 Feb; 37(2):164-9. PubMed ID: 9001138
[TBL] [Abstract][Full Text] [Related]
15. In vivo monitoring of fructose metabolism in the human liver by means of 31P magnetic resonance spectroscopy.
Segebarth C; Grivegnée AR; Longo R; Luyten PR; den Hollander JA
Biochimie; 1991 Jan; 73(1):105-8. PubMed ID: 2031955
[TBL] [Abstract][Full Text] [Related]
16. Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy.
Sijens PE; Ng TC
Magn Reson Imaging; 1992; 10(3):385-92. PubMed ID: 1406088
[TBL] [Abstract][Full Text] [Related]
17. Mapping the biodistribution and catabolism of 5-fluorouracil in tumor-bearing rats by chemical-shift selective 19F MR imaging.
Brix G; Bellemann ME; Haberkorn U; Gerlach L; Bachert P; Lorenz WJ
Magn Reson Med; 1995 Sep; 34(3):302-7. PubMed ID: 7500866
[TBL] [Abstract][Full Text] [Related]
18. Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver.
Murphy-Boesch J; Li CW; He L; Padavic-Shaller KA; Negendank W; Brown TR
Magn Reson Med; 1997 Mar; 37(3):321-6. PubMed ID: 9055218
[TBL] [Abstract][Full Text] [Related]
19. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma.
Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G
Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780
[TBL] [Abstract][Full Text] [Related]
20. [Measurement of intrahepatic triglyceride stores by 1H magnetic resonance spectroscopy: study with rat models and in patients].
Liu M; Gao X; Rao SX; Wu L; Zeng MS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):531-3. PubMed ID: 18649768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
